GFAP and glioblastoma: Pérez‐Larraya in 2014 published 2-step diagnostic algorithm using glial fibrillary acidic protein (GFAP) and YKL‐40 which differentiated patients with GBM from those with nonglial brain tumours with a sensitivity of 65% and a specificity of 78%26.